User profiles for Laila König
Laila KönigUniversity hospital Heidelberg Verified email at med.uni-heidelberg.de Cited by 1515 |
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?
Objective Long-term survival is rare in patients with glioblastoma (GBM). We set out to
determine prognostic factors for patients with favorable and poor prognosis in regard of tumor …
determine prognostic factors for patients with favorable and poor prognosis in regard of tumor …
Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone
Purpose We evaluated the influence of tumor location and tumor spread in primary
glioblastoma (GBM), with respect to the subventricular zone (SVZ), on recurrence behavior, …
glioblastoma (GBM), with respect to the subventricular zone (SVZ), on recurrence behavior, …
Intensity modulated radiation therapy (IMRT) with simultaneously integrated boost shortens treatment time and is noninferior to conventional radiation therapy followed …
…, A Hommertgen, MF Haefner, N Arians, L König… - International Journal of …, 2021 - Elsevier
Purpose In the modern era, improvements in radiation therapy techniques have paved the
way for simultaneous integrated boost irradiation in adjuvant breast radiation therapy after …
way for simultaneous integrated boost irradiation in adjuvant breast radiation therapy after …
[HTML][HTML] Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: initial clinical experience and patient-reported outcomes
Purpose/Objective Stereotactic body radiation therapy (SBRT) has emerged as a valid
treatment alternative for non-resectable liver metastases or hepatocellular carcinomas (HCC). …
treatment alternative for non-resectable liver metastases or hepatocellular carcinomas (HCC). …
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
L König, MF Häfner, S Katayama, SA Koerber… - Radiation …, 2020 - Springer
Introduction Local ablative treatment strategies are frequently offered to patients diagnosed
with oligometastatic disease. Stereotactic body radiotherapy (SBRT), as ablative treatment …
with oligometastatic disease. Stereotactic body radiotherapy (SBRT), as ablative treatment …
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
…, A Ottinger, V Izaguirre, F Putz, L König… - … journal of cancer, 2021 - Wiley Online Library
To report outcome (freedom from local progression [FFLP], overall survival [OS] and toxicity)
after stereotactic, palliative or highly conformal fractionated (>12) radiotherapy (SBRT, Pall‐…
after stereotactic, palliative or highly conformal fractionated (>12) radiotherapy (SBRT, Pall‐…
[HTML][HTML] Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations
…, T Eichkorn, T Held, J Ristau, C Rippke, L König… - Frontiers in …, 2022 - frontiersin.org
Purpose: To explore the benefit of adaptive magnetic resonance-guided stereotactic body
radiotherapy (MRgSBRT) for treatment of lung tumors in different locations with a focus on …
radiotherapy (MRgSBRT) for treatment of lung tumors in different locations with a focus on …
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)
…, D Machiraju, C Menzer, K Lang, L König… - …, 2022 - Taylor & Francis
In patients with melanoma brain metastases (MBM), a combination of radiotherapy (RT) with
immune checkpoint inhibitors (ICI) is routinely used. However, the best sequence of radio-…
immune checkpoint inhibitors (ICI) is routinely used. However, the best sequence of radio-…
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy
Background and purpose To investigate the prognostic impact of different histological
subtypes of non-small cell lung cancer (NSCLC) on outcome following stereotactic body …
subtypes of non-small cell lung cancer (NSCLC) on outcome following stereotactic body …
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
D Bernhardt, S Aufderstrasse, L König… - Cancer management …, 2018 - Taylor & Francis
Background Systemic inflammation appears to play a role in the progression of numerous
solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of …
solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of …